Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
136.81
-3.22 (-2.30%)
At close: Dec 5, 2025, 4:00 PM EST
138.38
+1.57 (1.15%)
After-hours: Dec 5, 2025, 7:48 PM EST

Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.
Inspire Medical Systems logo
Country United States
Founded 2007
IPO Date May 3, 2018
Industry Medical Devices
Sector Healthcare
Employees 1,246
CEO Timothy Herbert

Contact Details

Address:
5500 Wayzata Blvd., Suite 1600
Golden Valley, Minnesota 55416
United States
Phone (844) 672-4357
Website inspiresleep.com

Stock Details

Ticker Symbol INSP
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001609550
CUSIP Number 457730109
ISIN Number US4577301090
Employer ID 26-1377674
SIC Code 3841

Key Executives

Name Position
Timothy P. Herbert Founder, Chairman, Chief Executive Officer and President
Richard J. Buchholz Chief Financial Officer
Bryan K. Phillips J.D. Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Randall A. Ban Executive Vice President of Patient Access &Therapy Development
Carlton W. Weatherby Chief Strategy and Growth Officer
Jason P. Kelly Chief Operations and Quality Officer
Ezgi Yagci Vice President of Investor Relations
Melissa J. Mann Chief People Officer
John C. Rondoni Chief Product and Innovation Officer
Ivan Lubogo SVice President of Strategic Sales

Latest SEC Filings

Date Type Title
Dec 2, 2025 144 Filing
Nov 28, 2025 144 Filing
Nov 17, 2025 8-K Current Report
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 13, 2025 SCHEDULE 13G Filing
Nov 12, 2025 SCHEDULE 13G/A Filing
Nov 3, 2025 10-Q Quarterly Report
Nov 3, 2025 8-K Current Report
Oct 17, 2025 SCHEDULE 13G/A Filing
Oct 10, 2025 8-K Current Report